Ken Xie
Analyst · Fatima Boolani with UBS
The enterprise also, including some branch profits we do see some slowdown especially in the U.S. But it's -- on the other side, if you look at our product, which come out like the SoC4 come out 1 years ago, we started building a product like from 100F to 60F for the 40F, then we just announced 80F last week. So we can see the ramp-up, especially in the SMB, including the U.S., as it go up like over 40%. It's very, very strong. Internationally, we're a little bit behind on the U.S. to adopt some new products, including some -- both the low end using SoC4 and also the high end NP7, which is starting to release about like early this year and so starting to ramp up. So that's why we see the benefit of the new product, which easily have a performance like 4x, 5x better than the same cost, which we use in the - - we call security compute rating to benchmark compared to the other competitor is a huge advantage. So we see -- when we have the new product growth that come up very quickly after the testing evaluate on top of the product. But on the other side, the SD-WAN also gave the additional cost benefit, together with the new product cost performance benefit. So that's what helping driving the SMBs. We see it starting growing quite well. Also last quarter, after we announced the high end product, like 1 to 2 quarter, we starting to see the high end also starting to ramp up leverage NP7. So that's the trend. And I do believe sometime enterprise takes a little bit more time during this pandemic to do some deployment. But we do see a lot of evaluation going on. We do see some other interest, including combined, we call security networking together, we call secure-driven networking set the whole infrastructure. That's why the sales probably were more engage into the networking team. And also traditionally, more sales to security. Now as the networking team also starting engaged together with us to call secure-driven networking. So as we see the trend going on quite well. And also, like Keith mentioned, it's region by region, right? So it's a APAC staring to grow more very quickly, over 20%. And simply the pandemic kind of the situation maybe better recover a little bit better. And then we also see Europe probably also growing over 10%. The U.S. is a little bit slow, but we do believe later this year, next year that vaccines over, with the new product lineup, with the additional sales capacity we build, which we'll continue to invest, where we see very, very strong potential going forward.